1.22USD
25.45 MUSD
572.95 MUSD
8.09 M
About Taro Pharmaceutical Industries Ltd.
Sector
CEO
Uday Vijaykumar Baldota
Headquarters
Haifa Bay
Website
Employees (FY)
1.55 K
Founded
1950
ISIN
IL0010827181
FIGI
BBG000H2ZMR0
Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.
Dow drops 1,175 points :( #13 TARO)I know how to read my moving averages setup and use they in a discretionary way (Not a Mechanical System) combined with a support and resistance methodology and the observation of the candlesticks (Without using fancy candlestick names)
For example look the candlestick tail in the red circle for u
Uptrend intact - monitor on mild pullback for entry.Price may form a sideways consolidation phase before the next uptrend towards US$133.
Target: US$124, US$133
Support: US$110
TAROFound footing at support & has been traveling straight UP. Hard to chase here. Resistance looms.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of TARO is 42.23 USD — it has increased by 0.09% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Taro Pharmaceutical Industries Ltd. stocks are traded under the ticker TARO.
Taro Pharmaceutical Industries Ltd. is going to release the next earnings report on May 21, 2024. Keep track of upcoming events with our Earnings Calendar.
TARO stock is 0.28% volatile and has beta coefficient of 1.08. Check out the list of the most volatile stocks — is Taro Pharmaceutical Industries Ltd. there?
One year price forecast for Taro Pharmaceutical Industries Ltd. has a max estimate of 43.00 USD and a min estimate of 43.00 USD.
TARO earnings for the last quarter are 0.23 USD per share, whereas the estimation was 0.18 USD resulting in a 27.78% surprise. The estimated earnings for the next quarter are 0.30 USD per share. See more details about Taro Pharmaceutical Industries Ltd. earnings.
Taro Pharmaceutical Industries Ltd. revenue for the last quarter amounts to 148.20 M USD despite the estimated figure of 161.14 M USD. In the next quarter revenue is expected to reach 154.91 M USD.
Yes, you can track Taro Pharmaceutical Industries Ltd. financials in yearly and quarterly reports right on TradingView.
TARO stock has risen by 0.09% compared to the previous week, the month change is a 0.50% rise, over the last year Taro Pharmaceutical Industries Ltd. has showed a 69.48% increase.
TARO net income for the last quarter is 20.21 M USD, while the quarter before that showed 8.55 M USD of net income which accounts for 136.43% change. Track more Taro Pharmaceutical Industries Ltd. financial stats to get the full picture.
Today Taro Pharmaceutical Industries Ltd. has the market capitalization of 1.59 B, it has decreased by 0.24% over the last week.
Taro Pharmaceutical Industries Ltd. dividend yield was 0% in 2022, and payout ratio reached 0%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, TARO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Taro Pharmaceutical Industries Ltd. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 1.55 K employees. See our rating of the largest employees — is Taro Pharmaceutical Industries Ltd. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Taro Pharmaceutical Industries Ltd. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Taro Pharmaceutical Industries Ltd. stock shows the sell signal. See more of Taro Pharmaceutical Industries Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Taro Pharmaceutical Industries Ltd. future price: according to them, TARO price has a max estimate of 43.00 USD and a min estimate of 43.00 USD. Read a more detailed Taro Pharmaceutical Industries Ltd. forecast: see what analysts think of Taro Pharmaceutical Industries Ltd. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Taro Pharmaceutical Industries Ltd. EBITDA is 55.68 M USD, and current EBITDA margin is 8.70%. See more stats in Taro Pharmaceutical Industries Ltd. financial statements.